On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival.
Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.
Funding Rounds (2) - $31MUpdate
Early Stage Tech and Life Sciences
For 30 years the Mohr Davidow Ventures (MDV) team has invested in early stage technology-based...
Physic Ventures, based in San Francisco, provides capital and support to entrepreneurs focused on...
Global Private Equity & Venture Capital
Bessemer Venture Partners has over 100 years of investing experience, with a portfolio ranging...
610 Lincoln Street
3rd Floor, North Building
Waltham, MA 02451